|
US8592384B2
(en)
|
2005-04-04 |
2013-11-26 |
The Board Of Regents Of The University Of Texas System |
Micro-RNA's that regulate muscle cells
|
|
SG162726A1
(en)
*
|
2005-05-27 |
2010-07-29 |
San Raffaele Centro Fond |
Gene vector comprising mi-rna
|
|
EP2377559A1
(en)
*
|
2005-06-03 |
2011-10-19 |
Southern Adelaide Health Service - Flinders Medical Centre |
Targeting cells with altered microRNA expression
|
|
ES2397439T3
(es)
|
2006-08-01 |
2013-03-07 |
Board Of Regents Of The University Of Texas System |
Identificación de un microARN que activa la expresión de la cadena pesada beta de la miosina
|
|
WO2008071959A1
(en)
*
|
2006-12-12 |
2008-06-19 |
Oxford Biomedica (Uk) Limited |
Lentiviral vectors comprising micrornas
|
|
WO2008103755A1
(en)
*
|
2007-02-20 |
2008-08-28 |
Mayo Foundation For Medical Education And Research |
Treating cancer with viral nucleic acid
|
|
US8440636B2
(en)
|
2007-07-31 |
2013-05-14 |
The Board Of Regents, The University Of Texas System |
Micro-RNA family that modulates fibrosis and uses thereof
|
|
US8481507B2
(en)
|
2007-07-31 |
2013-07-09 |
The Board Of Regents, The University Of Texas System |
Micro-RNAs that control myosin expression and myofiber identity
|
|
JP5654352B2
(ja)
*
|
2007-11-09 |
2015-01-14 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
ｍｉＲ−１５ファミリーのマイクロＲＮＡによる心筋細胞生存及び心臓修復の調節
|
|
EP2265291B1
(en)
|
2008-03-17 |
2016-10-19 |
The Board of Regents of The University of Texas System |
Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration
|
|
WO2009142602A1
(en)
*
|
2008-05-19 |
2009-11-26 |
Agency For Science, Technology And Research |
Nucleic acid molecule and method of targeting gene expression to gliomas
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
US20100183558A1
(en)
|
2008-10-17 |
2010-07-22 |
Zhennan Lai |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
WO2010055413A1
(en)
|
2008-11-12 |
2010-05-20 |
Fondazione Centro San Raffaele Del Monte Tabor |
Gene vector for inducing transgene-specific immune tolerance
|
|
CN101787373B
(zh)
*
|
2009-01-23 |
2013-06-19 |
中国人民解放军第二军医大学东方肝胆外科医院 |
一种携带外源基因在包装细胞中高效生产的重组病毒载体、其构建方法及其用途
|
|
MX2011008190A
(es)
|
2009-02-04 |
2011-10-06 |
Univ Texas |
Direccionamiento dual de mir-208 y mir-499 en el tratamiento de trastornos cardiacos.
|
|
SG175821A1
(en)
*
|
2009-04-29 |
2011-12-29 |
Academisch Medisch Ct Bij De Univeriteit Van Amsterdam |
Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
|
|
EP2425001A4
(en)
*
|
2009-04-30 |
2012-11-14 |
Univ California |
ANTI-HIV COMBINATION VECTORS, TARGETING VECTORS AND METHOD OF USE
|
|
AU2010243276B2
(en)
|
2009-04-30 |
2016-09-15 |
Fondazione Telethon Ets |
Gene vector
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
DE102009050308A1
(de)
|
2009-10-22 |
2011-05-05 |
Ludwig-Maximilians-Universität München |
RNA mit einer Kombination aus unmodifizierten und modifizierten Nucleotiden zur Proteinexpression
|
|
BR112012002291A2
(pt)
*
|
2009-07-31 |
2016-11-29 |
Ethris Gmbh |
"polirribonucleotídeo com uma sequência que codifica uma proteína ou fragmento de proteína, implante, e, processo para a seleção de sequências de nucleotídeos"
|
|
WO2011020014A1
(en)
|
2009-08-14 |
2011-02-17 |
Regeneron Pharmaceuticals, Inc. |
Promoter-regulated differentiation-dependent self-deleting cassette
|
|
WO2011130749A2
(en)
|
2010-04-16 |
2011-10-20 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-hsv receptors
|
|
EP2561075B1
(en)
|
2010-04-23 |
2018-06-27 |
University of Massachusetts |
Aav-based treatment of cholesterol-related disorders
|
|
CA2833905C
(en)
|
2010-04-23 |
2019-09-10 |
University Of Massachusetts |
Multicistronic expression constructs
|
|
DK2826860T3
(en)
*
|
2010-04-23 |
2018-12-03 |
Univ Massachusetts |
CNS targeting AAV vectors and methods for their use
|
|
CN103097535A
(zh)
*
|
2010-07-12 |
2013-05-08 |
国立大学法人鸟取大学 |
利用miRNA导入的新型hiPSC制作法
|
|
US9309534B2
(en)
|
2010-07-12 |
2016-04-12 |
Universidad Autonoma De Barcelona |
Gene therapy composition for use in diabetes treatment
|
|
US9248144B2
(en)
|
2010-11-11 |
2016-02-02 |
University Of Miami |
Compositions, kits and methods for treatment of cardiovascular, immunological and inflammatory diseases
|
|
CN103380215A
(zh)
|
2010-12-15 |
2013-10-30 |
米拉根医疗公司 |
包含锁定核苷酸的微rna抑制剂
|
|
WO2012143401A1
(en)
|
2011-04-18 |
2012-10-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Tissue-specific regulation of transgene expression
|
|
EP3318634A1
(en)
|
2011-04-21 |
2018-05-09 |
University of Massachusetts |
Raav-based compositions and methods for treating diseases involving dominant-negative or gain of function mutations
|
|
JP6309450B2
(ja)
*
|
2011-08-04 |
2018-04-11 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
セロトニン関連の医学的状態、アドレナリン関連の医学的状態、ノルアドレナリン関連の医学的状態、グルタミン酸関連の医学的状態および副腎皮質刺激ホルモン放出ホルモン関連の医学的状態の処置および診断のためのミクロｒｎａおよび該ミクロｒｎａを含む組成物
|
|
HRP20192255T1
(hr)
|
2011-08-05 |
2020-03-06 |
Regeneron Pharmaceuticals, Inc. |
Humanizirani miševi s univerzalnim lakim lancem
|
|
WO2013043442A1
(en)
*
|
2011-09-23 |
2013-03-28 |
Dharmacon, Inc. |
The introduction of modular vector elements during production of a lentivirus
|
|
JP6177243B2
(ja)
|
2011-10-06 |
2017-08-09 |
ミラゲン セラピューティクス， インコーポレイテッド |
マイクロｒｎａの調節による全身エネルギーホメオスタシスの制御
|
|
EP2584040A1
(en)
|
2011-10-17 |
2013-04-24 |
Pharmahungary 2000 Kft. |
Compounds for treatment of ischemic injury
|
|
US10501513B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides for the production of oncology-related proteins and peptides
|
|
EP2834259A4
(en)
*
|
2012-04-02 |
2016-08-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US20150190532A1
(en)
|
2012-04-04 |
2015-07-09 |
The Trustees Of Columbia University In The City Of New York |
Smooth muscle specific inhibition for anti-restenotic therapy
|
|
CN103505743A
(zh)
*
|
2012-06-21 |
2014-01-15 |
北京命码生科科技有限公司 |
含功能性microRNA/siRNA的细胞微粒子及其应用
|
|
DK3354734T3
(da)
|
2012-06-21 |
2020-06-29 |
Miragen Therapeutics Inc |
Oligonukleotid-baserede hæmmere omfattende låst nukleinsyremønster
|
|
US9163235B2
(en)
|
2012-06-21 |
2015-10-20 |
MiRagen Therapeutics, Inc. |
Inhibitors of the miR-15 family of micro-RNAs
|
|
US9597380B2
(en)
|
2012-11-26 |
2017-03-21 |
Modernatx, Inc. |
Terminally modified RNA
|
|
JP2016504050A
(ja)
|
2013-01-17 |
2016-02-12 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
細胞表現型の改変のためのシグナルセンサーポリヌクレオチド
|
|
DK2956477T4
(da)
|
2013-02-15 |
2024-04-15 |
Bioverativ Therapeutics Inc |
Optimeret faktor viii-gen
|
|
ES2810800T3
(es)
|
2013-10-28 |
2021-03-09 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Vector de HSV oncolítico
|
|
US20150147774A1
(en)
*
|
2013-11-22 |
2015-05-28 |
National University Of Singapore |
Expression construct for yeast and a method of using the construct
|
|
US10072251B2
(en)
|
2014-02-19 |
2018-09-11 |
University Of Massachusetts |
Recombinant AAVS having useful transcytosis properties
|
|
AU2015231294B2
(en)
|
2014-03-18 |
2020-10-29 |
University Of Massachusetts |
rAAV-based compositions and methods for treating amyotrophic lateral sclerosis
|
|
WO2015164786A1
(en)
|
2014-04-25 |
2015-10-29 |
University Of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
|
US11008561B2
(en)
|
2014-06-30 |
2021-05-18 |
Bioverativ Therapeutics Inc. |
Optimized factor IX gene
|
|
CA2960912A1
(en)
|
2014-09-16 |
2016-03-24 |
Universitat Autonoma De Barcelona |
Adeno-associated viral vectors for the gene therapy of metabolic diseases
|
|
WO2016054554A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Massachusetts |
Heterologous targeting peptide grafted aavs
|
|
WO2016065001A1
(en)
|
2014-10-21 |
2016-04-28 |
University Of Massachusetts |
Recombinant aav variants and uses thereof
|
|
US11085055B2
(en)
|
2014-12-05 |
2021-08-10 |
Universitat Autonoma De Barcelona |
Viral vectors for the treatment of diabetes
|
|
US9885042B2
(en)
|
2015-01-20 |
2018-02-06 |
MiRagen Therapeutics, Inc. |
miR-92 inhibitors and uses thereof
|
|
US10584321B2
(en)
|
2015-02-13 |
2020-03-10 |
University Of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
CA3021949C
(en)
|
2015-04-24 |
2023-10-17 |
University Of Massachusetts |
Modified aav constructs and uses thereof
|
|
WO2017007994A1
(en)
|
2015-07-08 |
2017-01-12 |
American Gene Technologies International Inc. |
Hiv pre-immunization and immunotherapy
|
|
AU2016336344A1
(en)
|
2015-10-05 |
2018-04-19 |
Modernatx, Inc. |
Methods for therapeutic administration of messenger ribonucleic acid drugs
|
|
US10188750B1
(en)
|
2015-10-23 |
2019-01-29 |
University Of South Florida |
Self-replicating cell selective gene delivery compositions, methods, and uses thereof
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
IL310925A
(en)
|
2016-01-15 |
2024-04-01 |
American Gene Tech Int Inc |
Methods and compositons for the activation of gamma-delta t-cells
|
|
AR107469A1
(es)
|
2016-01-27 |
2018-05-02 |
Oncorus Inc |
Vectores virales oncolíticos y sus usos
|
|
KR20180118659A
(ko)
|
2016-02-01 |
2018-10-31 |
바이오버라티브 테라퓨틱스 인크. |
최적화된 viii 인자 유전자
|
|
US10888613B2
(en)
|
2016-02-08 |
2021-01-12 |
American Gene Technologies International Inc. |
Method of producing cells resistant to HIV infection
|
|
EP3413928B1
(en)
|
2016-02-12 |
2022-04-20 |
University of Massachusetts |
Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization
|
|
WO2017156311A2
(en)
|
2016-03-09 |
2017-09-14 |
American Gene Technologies International Inc. |
Combination vectors and methods for treating cancer
|
|
MA45052A
(fr)
*
|
2016-05-18 |
2019-03-27 |
Modernatx Inc |
Polynucléotides codant pour jagged1 pour le traitement du syndrome d'alagille
|
|
WO2017213697A1
(en)
|
2016-06-08 |
2017-12-14 |
American Gene Technologies International Inc. |
Non-integrating viral delivery system and methods related thereto
|
|
BR112019000015A2
(pt)
|
2016-06-30 |
2019-04-24 |
Oncorus, Inc. |
distribuição por vírus oncolítico pseudotipado de polipeptídeos terapêuticos
|
|
WO2018009246A1
(en)
|
2016-07-08 |
2018-01-11 |
American Gene Technologies International Inc. |
Hiv pre-immunization and immunotherapy
|
|
GB201612214D0
(en)
|
2016-07-14 |
2016-08-31 |
Univ Oxford Innovation Ltd |
Method
|
|
US11583562B2
(en)
|
2016-07-21 |
2023-02-21 |
American Gene Technologies International Inc. |
Viral vectors for treating Parkinson's disease
|
|
WO2018022747A1
(en)
*
|
2016-07-26 |
2018-02-01 |
Senti Biosciences, Inc. |
Genetic erasers
|
|
JP2018029521A
(ja)
*
|
2016-08-24 |
2018-03-01 |
国立研究開発法人農業・食品産業技術総合研究機構 |
ｍｉＲ３９８標的核酸配列を含む、遺伝子導入のためのウイルスベクター
|
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|
|
US11578340B2
(en)
|
2016-10-13 |
2023-02-14 |
University Of Massachusetts |
AAV capsid designs
|
|
CA3048313A1
(en)
|
2017-01-06 |
2018-07-12 |
Stabilitech Biopharma Ltd |
Virus
|
|
CN107384868A
(zh)
*
|
2017-02-17 |
2017-11-24 |
中国农业科学院上海兽医研究所 |
永生化原代绵羊肺细胞系的构建及其应用
|
|
CA3057142A1
(en)
|
2017-04-03 |
2018-10-11 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
|
MX2019013259A
(es)
*
|
2017-05-08 |
2020-01-13 |
Gritstone Oncology Inc |
Vectores de neoantigeno de alfavirus.
|
|
KR20250021608A
(ko)
|
2017-05-08 |
2025-02-13 |
플래그쉽 파이어니어링 이노베이션스 브이, 인크. |
막 융합을 촉진시키기 위한 조성물 및 그의 용도
|
|
EP3622073A4
(en)
|
2017-05-09 |
2021-01-06 |
University of Massachusetts |
METHOD FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
CA3099990A1
(en)
|
2017-05-12 |
2018-11-15 |
University Of Massachusetts |
Viral vector production
|
|
IL306098A
(en)
|
2017-05-24 |
2023-11-01 |
Univ Barcelona Autonoma |
Viral expression vectors containing the coding sequence for FIBROBLAST GROWTH FACTOR 21 (FGF21)
|
|
CN110770338A
(zh)
|
2017-06-16 |
2020-02-07 |
美国基因技术国际有限公司 |
由人γ-δ T细胞激活肿瘤细胞毒性的方法和组合物
|
|
US20190016802A1
(en)
|
2017-07-14 |
2019-01-17 |
Immatics Biotechnologies Gmbh |
Dual specificity polypeptide molecule
|
|
EP3658165A4
(en)
*
|
2017-07-26 |
2021-09-01 |
Oncorus, Inc. |
ONCOLYTIC VIRAL VECTORS AND THEIR USES
|
|
IT201700086403A1
(it)
*
|
2017-07-27 |
2019-01-27 |
Univ Del Piemonte Orientale |
Endothelial-specific promoter sequences and uses thereof
|
|
TWI904068B
(zh)
|
2017-08-09 |
2025-11-11 |
美商生物化學醫療公司 |
核酸分子及其用途
|
|
EP3444347A1
(en)
|
2017-08-18 |
2019-02-20 |
Universität Heidelberg |
Use of anti-crispr polypeptides for specific activation of cas nucleases
|
|
JP7397488B2
(ja)
|
2017-09-22 |
2023-12-13 |
ユニバーシティ オブ マサチューセッツ |
Ｓｏｄ１二重発現ベクターおよびその使用
|
|
CN117737009A
(zh)
|
2017-10-10 |
2024-03-22 |
南特生物科学公司 |
对病毒生产有效载荷具有低毒性的经修饰的ec7细胞
|
|
SG11202004926WA
(en)
|
2017-12-01 |
2020-06-29 |
Encoded Therapeutics Inc |
Engineered dna binding proteins
|
|
RS63078B1
(sr)
*
|
2017-12-15 |
2022-04-29 |
Medizinische Hochschule Hannover |
Poboljšano jedinjenje za lečenje srčane insuficijencije
|
|
US11865081B2
(en)
|
2017-12-29 |
2024-01-09 |
Virogin Biotech Canada Ltd. |
Oncolytic viral delivery of therapeutic polypeptides
|
|
EP4495597A3
(en)
|
2018-01-04 |
2025-04-30 |
Iconic Therapeutics LLC |
Anti-tissue factor antibodies, antibody-drug conjugates, and related methods
|
|
SG11202007114VA
(en)
|
2018-02-01 |
2020-08-28 |
Bioverativ Therapeutics Inc |
Use of lentiviral vectors expressing factor viii
|
|
US10716866B2
(en)
|
2018-03-29 |
2020-07-21 |
Generoath Co., Ltd |
Pharmaceutical composition comprising AIMP2-DX2 for preventing or treating neuronal diseases and use thereof
|
|
MX2020012295A
(es)
|
2018-05-15 |
2021-03-31 |
Flagship Pioneering Innovations V Inc |
Composiciones de fusosoma y usos de estas.
|
|
KR20210043574A
(ko)
|
2018-07-09 |
2021-04-21 |
플래그쉽 파이어니어링 이노베이션스 브이, 인크. |
푸소좀 조성물 및 이의 용도
|
|
WO2020033863A1
(en)
|
2018-08-09 |
2020-02-13 |
Bioverativ Therapeutics Inc. |
Nucleic acid molecules and uses thereof for non-viral gene therapy
|
|
KR20210102870A
(ko)
|
2018-08-30 |
2021-08-20 |
테나야 테라퓨틱스, 인코포레이티드 |
미오카르딘 및 ascl1을 사용한 심장 세포 재프로그래밍
|
|
EP3856762A1
(en)
|
2018-09-28 |
2021-08-04 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
US20210381001A1
(en)
*
|
2018-10-11 |
2021-12-09 |
Eidgenössische Technische Hochschule Zürich |
A method to treat disease using a nucleic acid vector encoding a highly compact multi-input logic gate
|
|
JP2022506515A
(ja)
|
2018-11-05 |
2022-01-17 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
制御性ｒｎａを発現させるためのベクターシステム
|
|
US20230043255A1
(en)
|
2018-11-14 |
2023-02-09 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for t cell delivery
|
|
EP3880832A1
(en)
|
2018-11-14 |
2021-09-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for hematopoietic stem cell delivery
|
|
AU2019378881A1
(en)
*
|
2018-11-14 |
2021-06-03 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for CNS delivery
|
|
JP2022513040A
(ja)
|
2018-11-14 |
2022-02-07 |
フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド |
コンパートメント特異的カーゴ送達のための組成物および方法
|
|
US11421273B2
(en)
*
|
2018-12-03 |
2022-08-23 |
California Institute Of Technology |
In situ readout of DNA barcodes
|
|
AU2019393880A1
(en)
|
2018-12-06 |
2021-07-15 |
Bioverativ Therapeutics Inc. |
Use of lentiviral vectors expressing factor IX
|
|
PE20211581A1
(es)
*
|
2018-12-21 |
2021-08-17 |
Univ Pennsylvania |
Composiciones para la reduccion de la expresion transgenica especifica de drg
|
|
MX2021008146A
(es)
*
|
2019-01-04 |
2021-10-13 |
Oncorus Inc |
Polinucleotidos de arn encapsulado y metodos de uso.
|
|
KR102248420B1
(ko)
*
|
2019-03-15 |
2021-05-06 |
주식회사 제너로스 |
miR-142-3p의 표적 서열을 포함하는 재조합 벡터
|
|
SG11202111279QA
(en)
*
|
2019-04-24 |
2021-11-29 |
Univ Pennsylvania |
Compositions useful in treatment of rett syndrome
|
|
BR112021024055A2
(pt)
|
2019-05-29 |
2022-02-08 |
Encoded Therapeutics Inc |
Composições e métodos para a regulação seletiva de gene
|
|
JP7457733B2
(ja)
|
2019-05-30 |
2024-03-28 |
グリットストーン バイオ インコーポレイテッド |
改変アデノウイルス
|
|
JP7651562B2
(ja)
|
2019-09-19 |
2025-03-26 |
ジェネトン |
Ｆｋｒｐの心毒性を軽減する遺伝子治療発現系
|
|
TW202126284A
(zh)
|
2019-09-30 |
2021-07-16 |
美商百歐維拉提夫治療公司 |
慢病毒載體配製物
|
|
KR102461417B1
(ko)
*
|
2019-11-11 |
2022-11-01 |
주식회사 온코크로스 |
아데노바이러스 벡터를 포함하는 전립선암 진단용 조성물
|
|
WO2021184006A1
(en)
*
|
2020-03-13 |
2021-09-16 |
Duke University |
Compositions for the treatment of nash and associated disorders and methods of using same
|
|
CA3173713A1
(en)
*
|
2020-03-30 |
2021-10-07 |
Uwe D. Staerz |
Enhancement of the production of adenovirus-based genetransfer vectors
|
|
CA3176788A1
(en)
*
|
2020-04-27 |
2021-11-04 |
The Trustees Of The University Of Pennsylvania |
Compositions useful in treatment of cdkl5 deficiency disorder (cdd)
|
|
EP4162059A1
(en)
*
|
2020-05-12 |
2023-04-12 |
The Trustees of The University of Pennsylvania |
Compositions for drg-specific reduction of transgene expression
|
|
WO2021255245A2
(en)
|
2020-06-19 |
2021-12-23 |
Genethon |
Gene therapy expression system allowing an adequate expression in the muscles and in the heart of sgcg
|
|
WO2021262963A1
(en)
|
2020-06-24 |
2021-12-30 |
Bioverativ Therapeutics Inc. |
Methods for the removal of free factor viii from preparations of lentiviral vectors modified to express said protein
|
|
CN116194587A
(zh)
|
2020-07-10 |
2023-05-30 |
吉尼松公司 |
一种新的肌肉特异性启动子
|
|
EP4192496A4
(en)
|
2020-08-06 |
2025-01-01 |
Gritstone bio, Inc. |
MULTIEPITOP VACCINE CASSETTES
|
|
BR112023002395A2
(pt)
|
2020-08-23 |
2023-03-21 |
Bioverativ Therapeutics Inc |
Sistema de baculovírus modificado para produção aprimorada de dna com extremidades fechadas (cedna)
|
|
KR102626543B1
(ko)
*
|
2020-09-14 |
2024-01-23 |
주식회사 제너로스 |
AIMP2-DX2 및 miR-142의 표적 핵산을 포함하는 재조합 벡터
|
|
KR20220035693A
(ko)
*
|
2020-09-14 |
2022-03-22 |
주식회사 제너로스 |
표적화된 유전자 전달을 위한 아데노-부속 바이러스 벡터
|
|
JP7121086B2
(ja)
*
|
2020-09-25 |
2022-08-17 |
ウニベルシダッド アウトノマ デ バルセロナ |
脂肪組織に形質導入するのに有用なアデノ随伴ウイルスベクター
|
|
WO2022070142A1
(en)
*
|
2020-09-30 |
2022-04-07 |
Generoath Co., Ltd. |
METHODS OF TREATING AGE-RELATED MACULAR DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR miR-142 AND COMPOSITIONS THEREOF
|
|
AU2022270361A1
(en)
|
2021-05-05 |
2023-11-16 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding prame
|
|
AU2022271727A1
(en)
*
|
2021-05-13 |
2023-12-14 |
Akouos, Inc. |
Gene therapy delivery compositions and methods for treating hearing loss
|
|
KR20240049332A
(ko)
|
2021-08-23 |
2024-04-16 |
바이오버라티브 테라퓨틱스 인크. |
최적화된 인자 viii 유전자
|
|
CA3229668A1
(en)
|
2021-08-23 |
2023-03-02 |
Bioverativ Therapeutics Inc. |
Baculovirus expression system
|
|
EP4408874A1
(en)
|
2021-09-30 |
2024-08-07 |
Bioverativ Therapeutics Inc. |
Nucleic acids encoding factor viii polypeptides with reduced immunogenicity
|
|
WO2023142040A1
(en)
*
|
2022-01-29 |
2023-08-03 |
Virogin Biotech Canada Ltd. |
Transcriptional and translational dual regulated oncolytic herpes simplex virus vectors
|
|
WO2023218430A1
(en)
*
|
2022-05-13 |
2023-11-16 |
Generoath Co., Ltd. |
Methods of treating retinal degenerative diseases using aimp2-dx2 and optionally a target sequence for mir‑142 and compositions thereof
|
|
AU2024299528A1
(en)
|
2023-07-24 |
2026-03-12 |
Strand Therapeutics Inc. |
Rna-based synthetic circuit for producing engineered immune cells for an extracorporeal cell therapy
|
|
US12281311B1
(en)
*
|
2024-02-20 |
2025-04-22 |
Wyvern Pharmaceuticals Inc. |
Composition for regulating production of interfering ribonucleic acid
|